MIRA Pharmaceuticals, Inc
Fundamentals
Oldest to newest| Line | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Net income | −$7.1M | −$12.0M | −$7.9M | −$10.4M |
| Operating cash flow | −$5.6M | −$4.5M | −$5.6M | −$4.7M |
| Cash | none on file | none on file | $2.8M | $6.3M |
| Shares outstanding | 13.3M | 14.8M | 16.6M | 41.9M |